Skip to main content
KORU Medical Systems, Inc. logo

KORU Medical Systems, Inc. — Investor Relations & Filings

Ticker · KRMD ISIN · US7599101026 US Manufacturing
Open in API
Filings indexed 922 across all filing types
Latest filing 2023-08-22 Director's Dealing
Country US United States of America
Listing US KRMD

About KORU Medical Systems, Inc.

https://www.korumedical.com/

KORU Medical Systems is a medical technology company that designs, develops, manufactures, and commercializes subcutaneous infusion solutions. The company's primary offering is the Freedom™ Infusion System, which includes syringe infusion pumps and related accessories. These systems are engineered for the delivery of large-volume subcutaneous drugs, such as immunoglobulins, to treat patients with chronic illnesses. KORU Medical Systems focuses on providing patient-centric solutions that facilitate safe and effective home-based infusion therapy, aiming to enhance patient quality of life by offering greater freedom and flexibility in treatment management.

Recent filings

Filing Released Lang Actions
FORM 4 FOR 08-18-2023
Director's Dealing
2023-08-22 English
FORM 4 FOR 08-16-2023
Director's Dealing
2023-08-17 English
FORM 10-Q QUARTERLY REPORT FOR 06-30-2023
Interim / Quarterly Report Q2 2023
2023-08-09 English
FORM 8-K CURRENT REPORT FOR AUGUST 9, 2023
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 9, 2023, reporting the company's financial results for the second quarter ended June 30, 2023, and updates to the full year financial outlook. It references a press release and a conference call about these results. The document includes detailed explanations of non-GAAP financial measures and their reconciliation, which are typical in earnings releases. The document is about the announcement of quarterly financial results, not a full quarterly report with comprehensive financial statements. Therefore, it fits the definition of an Earnings Release (ER). The document length is 6055 characters, which is consistent with an earnings release rather than a full interim report (IR).
2023-08-09 English
FORM 4 FOR 08-01-2023
Director's Dealing
2023-08-03 English
FORM 8-K CURRENT REPORT FOR JULY 27, 2023
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes a press release about preliminary second quarter revenues and business updates, and importantly, it details the resignation of the CFO and appointment of a new CFO along with amendments to the new CFO's employment agreement. There are no comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The document primarily announces management changes and related employment terms. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (6605 characters) and content confirm it is not merely an announcement of a report but a substantive filing about management changes.
2023-08-02 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.